Vesselon © 2019 

Vesselon is committed to saving lives and improving the quality of life for those suffering from terminal cancers and other serious diseases.

 

Our therapeutic immuno-oncology complexes are protected in circulation and actively targeted to tumors using an FDA approved lipid microsphere drug as the backbone of a proprietary encapsulated drug and drug platform technology. 

PIONEERING SOLUTIONS TO MEDICAL CHALLENGES

Protection in Circulation for Safer Drug Delivery

Targeting of Tumors without Changing the Drug

Tumor Biodistribution

Our technology allows a higher percentage of the injected dosage to penetrate into the tumor so that toxicity can be reduced and efficacy enhanced.

Cytokine Proteins

Monoclonal Antibodies

RNA and DNA

Viruses

Applicable Drug Classes